TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 107 filers reported holding TARSUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,389 | +303.3% | 3,736 | +310.1% | 0.00% | +100.0% |
| Q2 2023 | $16,461 | +149545.5% | 911 | +4.8% | 0.00% | – |
| Q1 2023 | $11 | 0.0% | 869 | +17.1% | 0.00% | – |
| Q4 2022 | $11 | -100.0% | 742 | -50.2% | 0.00% | – |
| Q3 2022 | $26,000 | -31.6% | 1,490 | -43.4% | 0.00% | -100.0% |
| Q2 2022 | $38,000 | -64.8% | 2,631 | -59.0% | 0.00% | 0.0% |
| Q1 2022 | $108,000 | +671.4% | 6,424 | +885.3% | 0.00% | – |
| Q4 2021 | $14,000 | +40.0% | 652 | +40.2% | 0.00% | – |
| Q3 2021 | $10,000 | -70.6% | 465 | -60.4% | 0.00% | -100.0% |
| Q2 2021 | $34,000 | +183.3% | 1,173 | +219.6% | 0.00% | – |
| Q1 2021 | $12,000 | -55.6% | 367 | -43.1% | 0.00% | -100.0% |
| Q4 2020 | $27,000 | – | 645 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,084,370 | $30,432,000 | 4.62% |
| Vivo Capital, LLC | 2,312,368 | $33,761,000 | 3.39% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $26,098,000 | 2.46% |
| Cormorant Asset Management, LP | 1,875,000 | $27,375,000 | 2.07% |
| Sands Capital Ventures, LLC | 260,000 | $3,796,000 | 1.04% |
| Ghost Tree Capital, LLC | 120,000 | $1,752,000 | 0.91% |
| RTW INVESTMENTS, LP | 2,013,601 | $29,399,000 | 0.76% |
| COWEN AND COMPANY, LLC | 534,524 | $7,804,000 | 0.75% |
| Perceptive Advisors | 1,296,416 | $18,927,000 | 0.59% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,324,214 | $19,334,000 | 0.40% |